EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-round infectious rotaviruses with deletions of VP7 or VP4 genes, based on SA11 and WC3 strain backbones, and their potential use as viral vectors

Tomohiro Kotaki, Yuta Kanai, Megumi Onishi, Yusuke Sakai, Daisuke Motooka, Zelin Chen, Yasutaka Enoki, Sayuri Komatsu, Katsuhisa Hirai, Shohei Minami, Takahiro Kawagishi, Hiroshi Ushijima und 1 weitere

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1013484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Tomohiro Kotaki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan. Hauptthemen laut MEDLINE: Capsid Proteins, Rotavirus, Rotavirus Vaccines, Antigens, Viral. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AMED, KAKENHI, JST Moonshot R&D-MILLENNIA Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single-round infectious rotavirus, which lacks a gene essential for virion assembly, serves not only as a safe and effective rotavirus vaccine but also as an orally-administrable viral vector vaccine that induces mucosal immunity. Previously, we generated a single-round infectious rotavirus by partially deleting the viral VP6 gene, and demonstrated its potential as a promising vaccine platform. However, this system has several limitations; namely, low viral protein expression levels and safety concerns. Here, we addressed these challenges by introducing large deletions into the VP7 or VP4 genes, which are dispensable for viral protein expression but essential for virion assembly. These VP7- or VP4-defective viruses exhibited markedly higher protein expression in wild-type MA104 cells than the previously developed VP6-defective virus. In addition, the large deletions reduce the risk of viral reversion, thereby increasing both efficacy and safety. In a mouse model, these viruses induced neutralizing antibodies at levels comparable with those elicited by wild-type rotavirus, indicating their potential as rotavirus vaccines. Moreover, a VP4-defective rotavirus harboring a heterologous gene achieved high expression of heterologous proteins, warranting its application as a viral vector vaccine. To further increase safety, we established a reverse genetics system for the bovine rotavirus WC3 strain, a parental strain of the licensed live attenuated rotavirus vaccine, and successfully generated a single-round VP4-defective rotavirus based on the WC3 backbone. Taken together, these optimizations facilitate development of safe and effective single-round infectious rotavirus platforms suitable for human use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Capsid ProteinsRotavirusRotavirus VaccinesAntigens, ViralRotavirus InfectionsGenetic VectorsAnimalsMiceMice, Inbred BALB CGene DeletionHumansAntibodies, ViralFemale

Substanzen

Capsid ProteinsRotavirus VaccinesAntigens, ViralVP4 protein, RotavirusVP7 protein, RotavirusAntibodies, Viral

Autor:innen und Institutionen

  • Department of Virology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.
  • Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
  • Department of Infection Metagenomics, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.
  • Center for Advanced Modalities and DDS, The University of Osaka, Osaka, Japan.
  • Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
  • Center for Infectious Disease Education and Research, The University of Osaka, Osaka, Japan.

ORCID-Profile: Takeshi Kobayashi

Förderung

  • AMED
  • KAKENHI
  • JST Moonshot R&D-MILLENNIA Program
  • The Research Foundation for Microbial Diseases of Osaka University
  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency
  • Moonshot Research and Development Program
  • BIKEN Foundation

Zitieren

APA

Kotaki, T., Kanai, Y., Onishi, M., Sakai, Y., Motooka, D., Chen, Z., Enoki, Y., Komatsu, S., Hirai, K., Minami, S., Kawagishi, T., Ushijima, H., & Kobayashi, T. (2025). Single-round infectious rotaviruses with deletions of VP7 or VP4 genes, based on SA11 and WC3 strain backbones, and their potential use as viral vectors. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013484

Vancouver

Kotaki T, Kanai Y, Onishi M, Sakai Y, Motooka D, Chen Z, et al. Single-round infectious rotaviruses with deletions of VP7 or VP4 genes, based on SA11 and WC3 strain backbones, and their potential use as viral vectors. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013484

BibTeX
@article{Kotaki2025,
  author = {Kotaki, Tomohiro and Kanai, Yuta and Onishi, Megumi and Sakai, Yusuke and Motooka, Daisuke and Chen, Zelin and Enoki, Yasutaka and Komatsu, Sayuri and Hirai, Katsuhisa and Minami, Shohei and Kawagishi, Takahiro and Ushijima, Hiroshi and Kobayashi, Takeshi},
  title = {Single-round infectious rotaviruses with deletions of VP7 or VP4 genes, based on SA11 and WC3 strain backbones, and their potential use as viral vectors},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1013484}
}
Kostenlos starten →